Harald zur Hausen
Harald zur Hausen (born March 11, 1936) is a prominent German virologist who was awarded the Nobel Prize in Physiology or Medicine in 2008 for his discovery of the role of human papillomavirus (HPV) in the development of cervical cancer.
Early Life and Education[edit]
Zur Hausen was born in Gelsenkirchen, Germany. He studied Medicine at the Universities of Bonn, Hamburg, and Düsseldorf, and completed his medical degree in 1960.
Career[edit]
After completing his medical degree, zur Hausen began his career as a researcher at the Institute for Microbiology in Düsseldorf. He later moved to the United States where he worked at the University of Pennsylvania and the Children's Hospital of Philadelphia.
In 1972, zur Hausen returned to Germany to take up a position as the head of the department of virology at the University of Erlangen-Nuremberg. In 1983, he became the Scientific Director of the German Cancer Research Center in Heidelberg, a position he held until his retirement in 2003.
Research and Achievements[edit]
Zur Hausen's most significant contribution to medical science is his discovery of the role of HPV in the development of cervical cancer. His research, which began in the early 1980s, led to the development of a vaccine against HPV, which has significantly reduced the incidence of cervical cancer worldwide.
In addition to his work on HPV, zur Hausen has also conducted important research on the Epstein-Barr virus, which is associated with several types of cancer, including Burkitt's lymphoma and nasopharyngeal carcinoma.
Awards and Honors[edit]
Zur Hausen has received numerous awards and honors for his contributions to medical science. In addition to the Nobel Prize, he has been awarded the Robert Koch Prize, the Paul Ehrlich and Ludwig Darmstaedter Prize, and the Prince Mahidol Award. He is also a member of several prestigious scientific societies, including the National Academy of Sciences and the European Academy of Sciences and Arts.
See Also[edit]
This medicine-related biographical article is a stub. You can help WikiMD by expanding it.
-
Harald zur Hausen
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
